These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. GM-CSF-secreting cancer immunotherapies: preclinical analysis of the mechanism of action. Simmons AD; Li B; Gonzalez-Edick M; Lin C; Moskalenko M; Du T; Creson J; VanRoey MJ; Jooss K Cancer Immunol Immunother; 2007 Oct; 56(10):1653-65. PubMed ID: 17410360 [TBL] [Abstract][Full Text] [Related]
26. CpG oligonucleotides enhance the tumor antigen-specific immune response of a granulocyte macrophage colony-stimulating factor-based vaccine strategy in neuroblastoma. Sandler AD; Chihara H; Kobayashi G; Zhu X; Miller MA; Scott DL; Krieg AM Cancer Res; 2003 Jan; 63(2):394-9. PubMed ID: 12543793 [TBL] [Abstract][Full Text] [Related]
27. Macrophage-colony stimulating factor is required for the production of neutrophil-promoting activity by mouse embryo fibroblasts deficient in G-CSF and GM-CSF. Zhang HH; Basu S; Wu F; Begley CG; Saris CJ; Dunn AR; Burgess AW; Walker F J Leukoc Biol; 2007 Oct; 82(4):915-25. PubMed ID: 17652450 [TBL] [Abstract][Full Text] [Related]
28. Combinational FLt3 ligand and granulocyte macrophage colony-stimulating factor treatment promotes enhanced tumor infiltration by dendritic cells and antitumor CD8(+) T-cell cross-priming but is ineffective as a therapy. Berhanu A; Huang J; Alber SM; Watkins SC; Storkus WJ Cancer Res; 2006 May; 66(9):4895-903. PubMed ID: 16651446 [TBL] [Abstract][Full Text] [Related]
29. The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma. von Mehren M; Arlen P; Gulley J; Rogatko A; Cooper HS; Meropol NJ; Alpaugh RK; Davey M; McLaughlin S; Beard MT; Tsang KY; Schlom J; Weiner LM Clin Cancer Res; 2001 May; 7(5):1181-91. PubMed ID: 11350882 [TBL] [Abstract][Full Text] [Related]
30. GM-CSF promotes differentiation of human dendritic cells and T lymphocytes toward a predominantly type 1 proinflammatory response. Eksioglu EA; Mahmood SS; Chang M; Reddy V Exp Hematol; 2007 Aug; 35(8):1163-71. PubMed ID: 17562355 [TBL] [Abstract][Full Text] [Related]
31. Bioimmunotherapy of rodent malaria: co-treatment with recombinant mouse granulocyte-macrophage colony-stimulating factor and an enkephalin fragment peptide Tyr-Gly-Gly. Kaur A; Kinhikar AG; Singh PP Acta Trop; 2004 Jun; 91(1):27-41. PubMed ID: 15158686 [TBL] [Abstract][Full Text] [Related]
32. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma. Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669 [TBL] [Abstract][Full Text] [Related]
33. Antitumor effect on murine renal cell carcinoma by autologous tumor vaccines genetically modified with granulocyte-macrophage colony-stimulating factor and interleukin-6 cells. Kinoshita Y; Kono T; Yasumoto R; Kishimoto T; Wang CY; Haas GP; Nishisaka N J Immunother; 2001; 24(3):205-11. PubMed ID: 11394497 [TBL] [Abstract][Full Text] [Related]
34. Induction of T-cell apoptosis in rats by genetically engineered glioma cells expressing granulocyte-macrophage colony-stimulating factor and B7.1. Tseng SH; Chen Y; Chang CJ; Tai KF; Lin SM; Hwang LH Clin Cancer Res; 2005 Feb; 11(4):1639-49. PubMed ID: 15746069 [TBL] [Abstract][Full Text] [Related]
35. GM-CSF transgene expression in the airway allows aerosolized ovalbumin to induce allergic sensitization in mice. Stämpfli MR; Wiley RE; Neigh GS; Gajewska BU; Lei XF; Snider DP; Xing Z; Jordana M J Clin Invest; 1998 Nov; 102(9):1704-14. PubMed ID: 9802884 [TBL] [Abstract][Full Text] [Related]